Navigation Links
'Pill' Won't Shorten Your Life: Study
Date:3/12/2010

And it may even be beneficial, researchers find

FRIDAY, March 12 (HealthDay News) -- Good news for women who have used birth control pills: A long-term study finds that those who took oral contraceptives at some point in their lives have a lower risk of death than women who never took the "Pill".

"Many women, especially those who used the first generation of oral contraceptives many years ago, are likely to be reassured by our results. However, our findings might not reflect the experience of women using oral contraceptives today, if currently available preparations have a different risk than earlier products," Dr. Philip Hannaford of the University of Aberdeen, leader of a new study, said in a statement.

However, those who took oral contraceptives are at higher risk of violent or accidental death. The authors of the study, which appears online March 12 in the journal BMJ, aren't sure why this that might be so.

Hannaford and colleagues tracked 46,000 women for up to almost 40 years.

In the long term, women who took birth-control pills had a significantly lower risk of death from causes like heart disease and cancers -- even cancers of the uterus and ovary -- compared to other women.

Women younger than 40 who took birth control pills had a slightly higher risk of death, the researchers report.

The authors conclude that, "oral contraception is not significantly associated with an increased long-term risk of death -- indeed a net benefit was apparent."

But, they write, "the balance of risks and benefits may vary globally, depending upon patterns of oral contraception usage and background risk of disease."

More information

For more about birth-control pills, try American College of Obstetricians and Gynecologists.



-- Randy Dotinga



SOURCE: BMJ, press release, March 11, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Pill box organizers increase HIV patients adherence and improve viral suppression
3. Human Papilloma Virus vaccines may decrease chances of oral cancer
4. Pill Equals Injection in Preventing Clots After Hip Replacement
5. Oil Spill Cleanup May Hurt Workers Lungs
6. Pillow, PAs Great American Sleep Better(TM)Project Reports Results
7. Research warns that human papillomavirus might cause bladder cancer
8. More than a pill: Complementary medicine can help with chronic pain
9. Do Not Take the Pill! Dr. Prudence Hall Tells her Teen and Female Patients
10. Video Pill Spots Hidden Crohns Disease
11. Pill Poses Little Cervical Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Schneider Insurance ... assistance to clients in southern Montana, is announcing a focused charity effort to ... The outreach programs offered by Zoo Montana provide students with current knowledge on ...
(Date:6/28/2017)... ... June 28, 2017 , ... Designers ... to communities in northern Virginia and DC, is announcing a cooperative charity event ... with Alzheimer’s and other disorders that lead to memory impairment. , The Insight ...
(Date:6/27/2017)... ... 27, 2017 , ... Excel Medical, the leader in Next-Generation ... of Executive Vice President, Sales and Marketing. Finnegan is a widely known industry ... sales leadership. He has received industry recognition for innovations and new approaches to ...
(Date:6/27/2017)... PA and London UK (PRWEB) , ... June 27, 2017 , ... ... applying to a clinical study is whether they can trust the sponsor to pay ... it is vital that sponsors and CROs establish payment strategies that encourage sites to ...
(Date:6/27/2017)... ... 27, 2017 , ... Salucro, the cloud-based payment platform that ... hospitals and provider groups, has announced that it will now offer Parasail’s payment ... a San Francisco health-finance startup that has launched a series of tech-based products ...
Breaking Medicine News(10 mins):
(Date:6/3/2017)...  Eli Lilly and Company (NYSE: ... Phase 3 MONARCH 2 study showed that abemaciclib, ... combination with fulvestrant, significantly improved progression-free survival (PFS) ... with hormone-receptor-positive (HR+), human epidermal growth factor receptor ... or progressed after endocrine therapy (median PFS, 16.4 ...
(Date:5/30/2017)... May 30, 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading ... today announced that it will be presenting at the 7th annual ... PT. Erez Raphael , CEO, of DarioHealth will be giving ... be held on June 6th & 7th, 2017 at the Luxe ... small / micro-cap space. About ...
(Date:5/29/2017)... 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... enables the functional selection of stem cells, today provided ... first quarter ended March 31 st , 2017. ... in the first quarter of 2017," said Dr. Shai ... announced the treatment of the first blood cancer patient ...
Breaking Medicine Technology: